Muscle characteristics of persons with fibromyalgia syndrome

NeuroRehabilitation

Volumn 23, Issue 3, 2008, Pages 217-230

  Jegede, Adejoke B ^a,b   Gilbert, Christopher ^b   Tulkin, Steven R ^a  

^a ALLIANT INTERNATIONAL UNIVERSITY   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

Agonist muscle; Antagonist muscle; Depression; Fibromyalgia; Muscle activity; Pain

Indexed keywords

ADULT; ARM MUSCLE; ARTICLE; BICEPS BRACHII MUSCLE; CHRONIC PAIN; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; EXTENSOR MUSCLE; FEMALE; FIBROMYALGIA; FLEXOR MUSCLE; FOREARM; GASTROCNEMIUS MUSCLE; HUMAN; LEG MUSCLE; MAJOR CLINICAL STUDY; MALE; MOOD; MUSCLE CONTRACTION; MUSCLE STRENGTH; PAIN ASSESSMENT; PHYSICAL PERFORMANCE; PSYCHOLOGICAL ASPECT; SELF REPORT; STERNOCLEIDOMASTOID MUSCLE; TIBIALIS ANTERIOR MUSCLE; TRICEPS BRACHII MUSCLE;

EID: 47949121612     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/nre-2008-23303     Document Type: Article

References (53)

1. A. Abeles, M. Pillinger, B. Soliater and M. Abeles, Narrative review: The pathophysiology of Fibromyalgia, Ann Intern Med 146 (2007), 726-734.
2. E. Bäckman, A. Bengtsson, M. Bengtsson, C. Lennmarken and K.G. Henriksson, Skeletal muscle function in primary fibromyalgia. Effect of regional sympathetic blockade with guanethidine, Acta Neurol Scand 77(3) (1988), 187-191.
3. J. Basmajian and C. De Luca, Muscles Alive: Their Function Revealed by Electromyography (5th ed.), New York: Williams & Wilkins, 1985.
4. A.T. Beck, R.A. Steer and G.K. Brown, Manual for the Beck Depression Inventory-II, San Antonio, TX: Psychological Corporation, 1996.
5. A.T. Beck, C.H. Ward, M. Mendelson, J. Mock and J. Erbaugh, An inventory for measuring depression, Archives of General Psychiatry 4 (1961), 561-571.
6. A. Bengtsson, K.G. Henriksson and J. Larson, Reduced high-energy Phosphate levels in the painful muscles of patients with fibromyalgia, Arthritis and Rheumatism 29(7) (1986), 817-821.
7. R.M. Bennett, Disordered growth hormone secretion in Fibromyalgia: A review of recent findings and a hypothesized etiology, Rheumatology (1998), 72-76.
8. P. Borman, R. Çeliker and Z. Hasçelik, Muscle performance in fibromyalgia syndrome, Rheumatology International 19 (1999), 27-30.
9. C.S. Burchardt, S.R. Clark and R.M. Bennett, The fibromyalgia impact questionnaire: Development and validation, Journal of Rheumatology 18(5) (1991), 728-733.
10. T. Burwinkle, J. Robinson and D. Turk, Fear of movement: Factor structure of the Tampa scale of kinesiophobia in patients with fibromyalgia syndrome, J Pain 6(6) (2005), 384-391.
11. D. Buskila, A. Shnaider, L. Neumann, D. Zilberman, N. Hilzenrat and E. Sikuler, Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship, Archives of Internal Medicine 157 (1997), 497-500.
12. G. Crombez, C. Eccleston and A. Van den Broeck, Hypervigilance to pain in Fibromyalgia: The Mediating Role of Pain Intensity and Catastrophic Thinking About Pain, Clinical Journal of Pain 20(2) (2004), 98-102.
13. C.C Donaldson, L.S. Snelling, A.L. MacInnis, G.E. Sella and H.H Mueller, Diffuse Muscular Coactivation (DMC) as a potential source of pain in fibromyalgia-Part 1, Neurorehabilitation 17 (2002), 33-39.
14. C.C Donaldson, L.S. Snelling, A.L. MacInnis, G.E. Sella and H.H Mueller, Diffuse Muscular Coactivation (DMC) in persons with fibromyalgia-Part 2, Neurorehabilitation 17 (2002), 41-48.
15. S.A. Epstein, G. Kay, D. Clauw, R. Heaton, D. Klein and L. Krupp, Psychiatric disorders in patients with fibromyalgia: a multicenter investigation, Psychosomatics 40 (1999), 57-63.
16. M. Ernberg, U. Voog and P. Alstergren, Plasma and serum serotonin levels and their relationship to orofacial pain and anxiety in fibromyalgia, Journal of Orofascial Pain 14 (2000), 37-46.
17. H. Fassbender and K. Martens, Critical considerations of the pathogenesis of soft-tissue rheumatism (fibromyalgia) and its therapeutic consequences, Z Orhop Ihre Grenzgeb 130 (1992), 99-103.
18. G. Ferraccioli, L. Ghirelli and F. Scita, EMG-Biofeedback training in fibromyalgia syndrome, Journal of Rheumatology 14(4) (1987), 820-825.
19. G. Ferraccioli et al., Neuroendocrinologic findings in primary fibromyalgia and in other chronic rheumatic conditions, Journal of Rheumatology 17(7) (1990), 869-873.
20. A. Field, Discovering Statistics using SPSS for Windows, The London fibromyalgia epidemiology study: Comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia vs. controls. California: Sage, 2000.
21. K.O. Forseth, J.T. Gran and G. Husby, A population study of the incidence of fibromyalgia among women aged 26-55 yr, British Journal of Rheumatology 36 (1997), 1318-1323.
22. R.T. Goldberg, W.N. Pachas and D. Keith, Relationship between traumatic events in childhood and chronic pain, Disability and Rehabilitation 21(1) (1999), 23-30.
23. W. Grassi, P. Core and G. Carlino, Capillary permeability in fibromyalgia, Journal of Rheumatology 21 (1994), 1328-1331.
24. E.N. Griep, J.W. Boersma and E.R. De-Kloet, Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome, Journal of Rheumatology 21 (1994), 2125-2130.
25. M. Gustafsson and Gatson-Johansson, Pain intensity and health locus of control: comparison of patients with fibromyalgia syndrome and rheumatoid arthritis, Patient Education and Counseling 29 (1996), 179-188.
26. I.M. Hurtig, R.I. Raak, S. Aspergren Kendall, B. Gerdle and W.M. Wahren, Quantitative sensory testing in fibromyalgia patients and in healthy subjects: Identification of subgroups, The Clinical Journal of Pain 17 (2001), 316-322.
27. E.C. Huskisson, Measurement of pain, Lancet 9 (1974), 1127-1131.
28. S. Jacobsen, M. Hoye-Madsen and B. Danneskiold-Samsoe, Screening for autoantibodies in patients with primary fibromyalgia syndrome and matched control group, Archives of Physical Medicine Rehabilitation 9 (1990), 655-658.
29. S.A. Jubrias, R.M. Bennett and G.A. Klug, Increased incidence of a resonance in the phosphodiester region of 31p nuclear magnetic resonance muscle of fibromyalgia patients, Arthritis and Rheumatism 23 (1994), 801-807.
30. N. Kurtze and S. Svebak, Fatigue and patterns of pain in fibromyalgia: Correlations with anxiety, depression and comorbidity in a female county sample, British Journal of Medical Psychology 74(4) (2001), 523-537.
31. M. Martinez-Levin, A novel explanation for the fibromyalgia enigma: Autonomic system dysfunction, Reprint from Fibromyalgia Frontiers 10(1) (2001).
32. P. Millea and R. Holloway, Treating fibromyalgia: Locations of standardized tender points of FMS, American Academy of Family Physicians 62 (2000), 1575-1582, 1587.
33. H. Moldofsky, P. Scarisbrick, R. England and H. Smythe, Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects, Psychosomatic Medicine 37 (1975), 341-351.
34. J. Norregaard, P.M. Bulow, E. Prescott, S. Jacobsen and B. Danneskiold-Samsoe, A four-year follow-up study in fibromyalgia. Relationship to chronic fatigue syndrome, Scandanavian Journal of Rheumatology 22 (1993), 35-38.
35. A. Okifuji and D.C. Turk, Stress and psychophysical dysregulation in patients with fibromyalgia syndrome, Applied Psychophysical and Biofeedback 27(2) (2002), 129-141.
36. P. Panek, J. Skowronski and E. Wagner, Differences on the projective hand test among chronic pain patients reporting three different pain experiences, Journal of Personality Assessment 79(2) (2002), 235-242.
37. J.H. Park, L.E. Kari and N.J. Olsen, Analysis of 31P MR spectroscopy data using artificial neural networks for longitudinal evaluation of muscle diseases; dermatomyositis, NMR in Biomedicine 11(4-5) (1998), 245-256.
38. J.H. Park, K.J. Niermann and N.J. Olsen, Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia, Current RheumatologyReports 2 (2000), 131-140.
39. M.H. Pope, R.B. Phillips, L.D. Haugh, C. Hsieh, L. MacDonald and S. Haldeman, A prospective randomized three-week trial of spinal manipulation, transcutaneous muscle stimulation, massage, and corset in the treatment of subacute low backpain, Spine 19 (1994), 2571-2577.
40. S.I. Reville, J.O. Robinson, M. Rosen and M.I. Hugg, The reliability of a linear analogue for evaluation of pain, Anesthesia 31 (1976), 1191-1198.
41. S. Roland and M. Domingo, Evidence for abnormal pain processing in Fibromyalgia syndrome, Pain Medicine 2(3) (2001), 208-215.
42. J. Russell, G. Vipraio and W. Morgan, Is there a metabolic basis for fibrositis syndrome? American Journal of Medicine 81 (1986), 50-54.
43. R. Sansone, J. Levengood and M. Sellbom, Psychological aspects of fibromyalgia research vs. clinician impressions, Journal of Psychosomatic Research 56(2) (2004), 185-188.
44. H. Sarnoch, F. Adler and O.B. Scholz, Relevance of muscular sensitivity, muscular activity, and cognitive variables for pain reduction associated with EMG biofeedback in fibromyalgia, Perceptual and Motor Skills 84 (1997), 1043-1050.
45. W. Smith, Fibromyalgia syndrome, Orthopedic Nursing 33(4) (1998), 653-669.
46. D. Turk, J. Robinson and T. Burwinkle, Prevalnce of fear of pain and activity in patients with fibromyalgia syndrome, J Pain 5(9) (2004), 483-490.
47. K.P. White, M. Speechley and M. Harth, The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls, The Journal of Rheumatology 26(7) (1999), 1577-1585.
48. R. Staud, Biology and therapy of fibromyalgia: Pain in the fibromyalgia syndrome, Arthritis Research & Therapy 8(3), (2006), 208-215.
49. J. Turk, J. Sluiter, M. Frings-Dresen, M. Goossens, P. Thibault, K. Boersma and J. Vlaeyen, Fear of movement and (re)injury in chronic musuloskeletal pain: Evidence for an invariant two-factor model of the Tampa Scale for kinesiophobia across pain diagnoses and Dutch, Swedish, and Canadian samples, J Pain 6(6), 007), 384-391.
50. F. Wolfe, Clinical, laboratory, and radiographic assessments, Current Opinions on Rheumatology 5 (1993), 138-145.
51. F. Wolfe, D. Hawley and K. Wilson, The prevalence and meaning of fatigue in rheumatic disease, Journal of Rheumatology 23 (1996), 1407-1416.
52. F. Wolfe, K. Ross and J. Anderson, The prevalence and characteristics of fibromyalgia in the general population, Arthritis & Rheumatism 38 (1995), 19-28.
53. F. Wolfe, H. Smythe and M.B. Yunus, The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee, Arthritis & Rheumatism 33 (1990), 160-172.